MT-4
CAS No. 2327925-35-7
MT-4( —— )
Catalog No. M33223 CAS No. 2327925-35-7
MT-4 inhibits the adhesion of ovarian cancer (OC) cells to the peritoneum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | Get Quote |
|
| 5MG | 141 | Get Quote |
|
| 10MG | 226 | Get Quote |
|
| 25MG | 365 | Get Quote |
|
| 50MG | 522 | Get Quote |
|
| 100MG | 691 | Get Quote |
|
| 500MG | 1386 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMT-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionMT-4 inhibits the adhesion of ovarian cancer (OC) cells to the peritoneum.
-
DescriptionMT-4 blocks the TG2/FN complex at the interface between cancer cells and the tumor niche. MT-4 inhibits the adhesion of ovarian cancer (OC) cells to the peritoneum.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2327925-35-7
-
Formula Weight361.44
-
Molecular FormulaC21H23N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (276.67 mM; Ultrasonic )
-
SMILESCN(C)c1cc(C)nc(Nc2ccc(NC(=O)Cc3ccccc3)cc2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sima LE, et al. Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin. Mol Cancer Ther. 2019 Jun;18(6):1057-1068.?
molnova catalog
related products
-
Labetuzumab
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
-
Metamorphosin A
Metamorphosin A
-
Boeravinone B
Boeravinone B, a novel efflux pump inhibitor, apart from inhibiting the MdeA mediated efflux, also significantly inhibit the biofilm formation of S. aureus, boeravinone B may be used in combination with mupirocin for further development.
Cart
sales@molnova.com